^
Association details:
| Biomarker: | TNFRSF4 expression |
|---|---|
| Cancer: | Acute Myelogenous Leukemia |
| Drug: | Bavencio (avelumab) (PD-L1 inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Single-Cell Mass Cytometry Identifies Mechanisms of Resistance to Immunotherapy in AML
Published date:
11/06/2019
Excerpt:
Expression of PD-L2, OX40, and TIM-3 was detected in the majority of these resistant clones (100%, 86%, and 71%, respectively).
DOI:
10.1182/blood-2019-128601
